PhaseWell Research
Business Services · Tennessee, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3200 West End Ave Ste 200, Nashville, Te...Website
www.phasewell.comRevenue
$5.5 MillionIndustry
About PhaseWell Research
PhaseWell Research Org Chart
Is PhaseWell Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
PhaseWell Research, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when PhaseWell Research launches new products
Congratulate Masked Content for being promoted to Masked Content at PhaseWell Research
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on PhaseWell Research recently announced quarterly report
Click to see if PhaseWell Research had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if PhaseWell Research has recently received funding, and reach out quickly before it becomes old news!
Check out if PhaseWell Research is spiking on competitors!
Funding: Get notified immidiatlly once PhaseWell Research has new funding data
Recommended Actions
Reach out to Masked Content who joined PhaseWell Research as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
PhaseWell Research is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PhaseWell Research is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PhaseWell Research.
PhaseWell Research Tech Stack
A closer look at the technologies used by PhaseWell Research
Top Business Services Companies
Frequently Asked Questions Regarding PhaseWell Research
PhaseWell Research is dedicated to connecting communities to clinical trials, aiming to expedite the delivery of life-changing treatments to patients. Established in 2024, the company leverages a network of trusted research sites to conduct phase I-IV clinical trial services across various therapeutic areas, including oncology, central nervous syst... Read More